Thomas Catinazzo - Apr 28, 2025 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Chief Financial Officer
Signature
/s/ Brian Adams, as Attorney-in-Fact
Stock symbol
RLAY
Transactions as of
Apr 28, 2025
Transactions value $
-$58,849
Form type
4
Date filed
4/30/2025, 08:24 PM
Previous filing
Mar 31, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale -$5.42K -1.71K -0.46% $3.17 373K Apr 28, 2025 Direct F1, F2
transaction RLAY Common Stock Sale -$3.11K -981 -0.26% $3.17 372K Apr 28, 2025 Direct F2, F3
transaction RLAY Common Stock Sale -$11.5K -3.56K -0.96% $3.23 368K Apr 29, 2025 Direct F2, F3
transaction RLAY Common Stock Sale -$38.8K -12.9K -3.51% $3.00 355K Apr 30, 2025 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,722 shares of restricted stock units ("RSUs") on April 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 248,632 shares underlying RSUs.
F3 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2024.
F4 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,392 shares of RSUs on April 29, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F5 Includes 206,240 shares underlying RSUs.